Next generation sequencing-based analyses of hematological malignancies.

May 1, 2017

Professor Christian Thiede describes the work his lab at the University Hospital Carl Gustav Carus in Dresden, Germany, using NGS to address the complex molecular genetics of hematological malignancies. In addition, he presents performance data of the myeloid panel across multiple instrument platforms and highlights from the European ELAN (Evaluation of NGS in AML Diagnostics) inter-laboratory study, for which he was the coordinator. For Research Use Only. Not for use in diagnostic procedures.

Share this article on